The role of the coagulation cascade in the continuum of sepsis and acute lung injury and acute respiratory distress syndrome - PubMed (original) (raw)
Review
The role of the coagulation cascade in the continuum of sepsis and acute lung injury and acute respiratory distress syndrome
Julie A Bastarache et al. Semin Respir Crit Care Med. 2006 Aug.
Abstract
Sepsis is a common and life-threatening condition with a high mortality rate. Severe sepsis includes multiorgan dysfunction syndrome. The organ most often affected is the lung, with development of acute lung injury (ALI), which, in its most severe form, is referred to as acute respiratory distress syndrome (ARDS). Our understanding of inflammation in the pathogenesis of sepsis and ALI is continually growing. However, therapies aimed at the inflammatory cascade in sepsis have been unsuccessful. These failures have led investigators to consider other pathways that may be important in the development of sepsis and ALI, including the coagulation and fibrinolytic cascades. In fact, the first therapy to reduce mortality in sepsis modulates the coagulation cascade. With this clinical success, administration of drotecogin alfa (recombinant activated protein C), the importance of coagulation in the pathogenesis of human sepsis is becoming clearer. This review summarizes the current understanding of the role of coagulation and fibrinolytic abnormalities in sepsis and the development of ALI and ARDS. Both in vitro and in vivo studies of the role of the coagulation cascade in sepsis and lung injury will be discussed, including initiation of coagulation through modulation of tissue factor and tissue factor pathway inhibitor, propagation of coagulation via protein C and thrombomodulin, inhibition of thrombin generation and resolution through thrombolysis by plasminogen activator, and plasminogen activator inhibitor-1.
Similar articles
- Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S. Idell S. Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. doi: 10.1097/01.CCM.0000057846.21303.AB. Crit Care Med. 2003. PMID: 12682443 Review. - Anticoagulant therapy in acute lung injury.
Laterre PF, Wittebole X, Dhainaut JF. Laterre PF, et al. Crit Care Med. 2003 Apr;31(4 Suppl):S329-36. doi: 10.1097/01.CCM.0000057912.71499.A5. Crit Care Med. 2003. PMID: 12682461 Review. - Genetics of coagulation factors in acute lung injury.
Russell JA. Russell JA. Crit Care Med. 2003 Apr;31(4 Suppl):S243-7. doi: 10.1097/01.CCM.0000057870.61079.3E. Crit Care Med. 2003. PMID: 12682447 Review. - Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia--a review.
Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS. Schultz MJ, et al. Crit Care Med. 2006 Mar;34(3):871-7. Crit Care Med. 2006. PMID: 16521285 Review. - Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
Carvalho AC, DeMarinis S, Scott CF, Silver LD, Schmaier AH, Colman RW. Carvalho AC, et al. J Lab Clin Med. 1988 Aug;112(2):270-7. J Lab Clin Med. 1988. PMID: 3397629
Cited by
- Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review.
Barrett CD, Moore HB, Moore EE, McIntyre RC, Moore PK, Burke J, Hua F, Apgar J, Talmor DS, Sauaia A, Liptzin DR, Veress LA, Yaffe MB. Barrett CD, et al. Res Pract Thromb Haemost. 2020 Jun 12;4(4):524-531. doi: 10.1002/rth2.12357. eCollection 2020 May. Res Pract Thromb Haemost. 2020. PMID: 32542213 Free PMC article. Review. - Protective effects of lavender oil on sepsis-induced acute lung injury via regulation of the NF-κB pathway.
Xie Q, Wang Y, Zou GL. Xie Q, et al. Pharm Biol. 2022 Dec;60(1):968-978. doi: 10.1080/13880209.2022.2067570. Pharm Biol. 2022. PMID: 35588105 Free PMC article. - An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals.
Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM; Acute Lung Injury in Animals Study Group. Matute-Bello G, et al. Am J Respir Cell Mol Biol. 2011 May;44(5):725-38. doi: 10.1165/rcmb.2009-0210ST. Am J Respir Cell Mol Biol. 2011. PMID: 21531958 Free PMC article. - Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome.
Sebag SC, Bastarache JA, Ware LB. Sebag SC, et al. Curr Pharm Biotechnol. 2011 Sep;12(9):1481-96. doi: 10.2174/138920111798281171. Curr Pharm Biotechnol. 2011. PMID: 21401517 Free PMC article. Review. - Nebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysis.
Glas GJ, Serpa Neto A, Horn J, Cochran A, Dixon B, Elamin EM, Faraklas I, Dissanaike S, Miller AC, Schultz MJ. Glas GJ, et al. Ann Intensive Care. 2016 Dec;6(1):33. doi: 10.1186/s13613-016-0138-4. Epub 2016 Apr 16. Ann Intensive Care. 2016. PMID: 27083915 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical